-
Sector Analysis
NewPlastics Market Analysis and Forecast by Products, Capacity Additions, Top Countries and Active and Upcoming Projects to 2030
Plastics Market Report Overview The plastics market has shown robust and consistent growth and is projected to record a healthy CAGR of 2% during 2024-2030. Constantly evolving lifestyles, the growth of the retail sector, and the increasing construction activities in emerging countries are the factors driving the plastics market growth. Asia continues to dominate global plastics consumption due to rapid economic growth in China, India, South Korea, and Japan. Plastics Market Analysis by Regions, 2023 (%) Buy the Full Report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fluticasone Propionate in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fluticasone Propionate in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fluticasone Propionate in Osteoarthritis Pain Drug Details: Fluticasone propionate (EP-104) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Fluticasone Propionate in Eosinophilic Esophagitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fluticasone Propionate in Eosinophilic Esophagitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fluticasone Propionate in Eosinophilic Esophagitis Drug Details: Fluticasone propionate (EP-104) is...
-
Thematic Analysis
Oil and Gas M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Oil & Gas Sector
-
Product Insights
Electrophysiology Diagnostic Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Diagnostic Catheters Pipeline Market Report Overview Electrophysiology Diagnostic Catheters are used for temporary intracardiac sensing, recording, stimulation, and mapping. These catheters include a tube with an electrode at its end that is threaded through an artery into the heart to record electrical activity. It can also emit electrical impulses and detect the heart’s response. Steerable Diagnostic Catheters is the only segment in the Electrophysiology Diagnostic Catheters pipeline market. The Electrophysiology Diagnostic Catheters pipeline market research report provides a comprehensive...
-
Company Insights
Innovation and Patenting activity of EPS Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of EPS Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-282 in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-282 in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-282 in Inflammation Drug Details: EP-282 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-547 in Pruritus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Pruritus Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to primary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-282 in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-282 in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EP-282 in Inflammation Drug Details:EP-282 is under development for the treatment of intestinal infection,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Migraine Drug Details: Oxytocin (TI-001) is under development for the treatment...